This is the authors' abstract. We don't add key points for this paper.
Our findings identify miR-22 as a critical regulator in the control of thermogenesis in BAT and as a potential therapeutic target for human metabolic disorders.
No takes yet. Share an insight, caveat, or question.
Lou et al. (2021) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: